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Introduction: Intracerebral hemorrhage (ICH) at high altitude is not well understood to date. This study
investigates the effects of high altitude on ICH, and examines the acute neuroprotection of hyperbaric oxygen
(HBO) therapy against high-altitude ICH.
Methods: Minipigs were placed in a hypobaric chamber for 72 h before the operation. ICH was induced by an
infusion of autologous arterial blood (3 ml) into the right basal ganglia. Animals in the high-altitude ICH group
received HBO therapy (2.5 ATA for 60 min) 30 min after ICH. Blood gas, blood glucose and brain tissue oxygen
partial pressure (PbtO2) were monitored continuously for animals from all groups, as were microdialysis products
including glucose, lactate, pyruvate and glutamate in perihematomal tissue from 3 to 12 h post-ICH.
Results: High-altitude ICH animals showed significantly lower PbtO2, higher lactate/pyruvate ratio (LPR) and
glutamate levels than low-altitude ICH animals. More severe neurological deficits, brain edema and neuronal
damage were also observed in high-altitude ICH. After HBO therapy, PbtO2 was significantly increased and LPR
and glutamate levels were significantly decreased. Brain edema, neurological deficits and neuronal damage were
also ameliorated.
Conclusions: The data suggested a more serious disturbance of tissue oxygenation and cerebral metabolism in the
acute stage after ICH at high altitude. Early HBO treatment reduced acute brain injury, perhaps through a
mechanism involving the amelioration of the derangement of cerebral oxygenation and metabolism following
high-altitude ICH.Introduction
Intracerebral hemorrhage (ICH) is the second most
common and the deadliest subtype of stroke, with a high
mortality rate [1]. It represents between 10 and 15 % of
all strokes that occur in the US, Europe and Australia,
and between 20 and 30 % of all strokes that occur in
Asian countries [2]. The 30-day mortality rate is ap-
proximately 40 %. Furthermore, ICH has a significant
morbidity among individuals who survive, and only 20 %
of survivors are independent at six months post-stroke.
A growing number of people travel to, or reside at alti-
tudes higher than 2,500 m, such as the North American
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million people live permanently in high-altitude regions
and their health needs more public awareness. Acute
mountain sickness, high-altitude cerebral edema and
high-altitude pulmonary edema comprise the main com-
ponents of high-altitude illnesses. However, less well
known are the other conditions, chiefly neurological,
that may arise completely outside the usual definition of
altitude sickness [3]. Stroke is outside the focus of the
majority, and remains a major disease that seriously
threatens the health of the people living at high altitudes.
Some of the few studies on this subject have reported
that long-term residence at high altitudes was associated
with a higher risk of stroke, almost 10 times greater than
residence at low altitude [4, 5]. Moreover, stroke at a
younger age occurs more frequently at high altitude than
at low altitude [6]. Another study showed ICH to be thele distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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higher disability and mortality rates than at low
altitude [7]. The etiology and clinical manifestations
of high-altitude ICH are quite different from those
of low-altitude ICH. Thus far, we know little about
secondary brain injury and the pathophysiology related
to high-altitude ICH; thus, effective therapy for this
disease is also very limited.
Several cerebral monitoring techniques permit con-
tinuous monitoring of cerebral physiology, such as brain
tissue oxygen partial pressure (PbtO2) and neurochem-
istry [8, 9]. Use of these modalities is beneficial to
optimize brain oxygen utilization and metabolism in pa-
tients with acute brain injury. It may provide an ex-
tended window for the prevention, early detection and
treatment of ongoing secondary neuronal injury, and
help to improve outcomes after ICH [10, 11]. However,
the changes in cerebral oxygenation and metabolism in
the early stage of high-altitude ICH, and the differences
between high-altitude and low-altitude ICH regarding
these parameters are unknown.
Early hyperbaric oxygen (HBO) therapy mitigates
blood–brain barrier disruption and facilitates angiogen-
esis after ICH. HBO therapy also reduces secondary
hemorrhage after focal cerebral ischemia [12]. The
amount of oxygen that is dissolved in plasma and tissues
can be elevated dramatically via raising the pressure and
oxygen content of inspired air. This may improve the
aerobic and neurochemical milieu in the injured brain
region [13]. Hypobaric hypoxia, a prime characteristic of
high-altitude areas, is a risk factor for high-altitude
stroke [5, 14]. Thus, treatment of high-altitude-induced
hypoxemia using HBO is logical and necessary. However,
the effects of HBO on acute brain injury induced by
high-altitude ICH have not been reported. Currently the
underlying mechanisms of HBO treatment, especially
cerebral oxygenation and metabolism, are not well
understood.
Previously, we established a porcine model of high-
altitude ICH, and observed more severe tissue lesion
and neurological deficit seven days after ICH at high
altitude compared to low altitude [15]. In this study, one
goal was to evaluate the differences between low-altitude
and high-altitude ICH with regards to cerebral oxygen-
ation and metabolism in the acute stage (within 12 h) of
porcine ICH. The other goal was to evaluate the effects
of early treatment with HBO on brain damage in high-
altitude ICH via multimodality monitoring.
Methods
Animals
Forty-two male Guizhou Congjiang minipig (China) (15
to 20 kg) were obtained from the Experimental Animal
Center of the Third Military Medical University,Chongqing, China. All experiments were conducted in
accordance with animal care guidelines approved by the
Animal Ethics Committee of the Third Military Medical
University. The animals were housed with a 12-hour
light/dark cycle and water and food provided ad libitum.
They were randomly divided into five groups: plain
(low-altitude) sham operation group (PS, six animals),
plain blood-infusion group (PI, 10 animals), high-
altitude sham operation group (HS, six animals), high-
altitude blood-infusion group (HI, 10 animals) and
high-altitude blood-infusion plus HBO therapy group
(HI-HBO, 10 animals). PI, HI and HI-HBO animals
received autologous arterial blood infusions; PS and
HS animals received the same surgery but no blood
infusions. The schematic representation of experimental
timeline is shown in Fig. 1a.
Animal surgical preparation
Pigs were initially anesthetized with ketamine (25 mg/kg
Hengrui, Jiangsu, China) administered intramuscularly.
After sedation, pentobarbital (30 mg/kg Xinya, Shanghai,
China) was administered through an ear vein to achieve
a deep surgical level of anesthesia. After placement of
the femoral vein catheter, pentobarbital was infused at a
rate of 10 mg/kg per hour until 12 h after ICH. Core
temperature was measured with a rectal thermistor
probe (Daxiong, Shenzhen, China). The right femoral ar-
tery was catheterized for mean arterial pressure (MAP)
monitoring, and to permit the withdrawal of blood sam-
ples for determination of respiratory gases, acid–base
status and glucose concentrations every three hours
(Table 1).
Intracerebral blood infusion
Surgery was performed as described previously, with mod-
erate modifications [15, 16]. Each animal’s head was
shaved and disinfected, and fully aseptic techniques were
used. Three burr holes (2 mm in diameter) were drilled in
the cranium: hole A (10 mm right, 2 mm posterior, for
blood infusion), hole B (8 mm right, 8 mm posterior, for
PbtO2 monitoring) and hole C (16 mm right, 8 mm pos-
terior, for MD monitoring) (Fig. 1b). The right was relative
to the sagittal suture, and the posterior was relative to the
coronal suture. A 22-gauge sterile intravenous catheter
(0.8 mm diameter, 25 mm long, Jierui, Weihai, China) was
placed stereotaxically into the right basal ganglia (25 mm
below the skull) and fixed firmly to the skull. Then, blood
(1 ml) extracted from the right femoral artery was injected
slowly into brain tissue through the inner cannula. A rate
of 0.2 ml/min was controlled using a high-pressure syr-
inge pump (Longerpump, Hebei, China). After blood infu-
sion, the needle core was inserted into the inner cannula
and maintained for 10 min. Next, the needle core was ex-
tracted and another 2 ml blood was injected slowly at the
Fig. 1 The ICH induction and the positioning of the probes. a The schematic representation of the experimental timeline. b Schematic drawing
of catheter positioning relative to the injection site of the hematoma in the minipig cranium. c The relative position of the PbtO2 probe and MD
probe in perihematomal tissue were confirmed using computed tomography
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tained for 20 min, before the skull holes were sealed with
bone wax.
Experimental hypobaric hypoxia
To simulate hypobaric hypoxia, a hypobaric chamber
(Moon, Yantai, China) was used. HS, HI and HI-HBO
animals were placed in the temperature-controlled hypo-
baric chamber (20 ± 1 °C) for 72 h; the normal air in the
chamber was adjusted to 0.6 ATA pressure, 14.5 % oxy-
gen content (simulating an altitude of 4,000 m). The
chamber was opened twice a day (for approximately
30 min each day) for feeding and cleaning. We slowly in-
creased the air pressure in the chamber until it reached
the normal atmospheric pressure of our laboratory
(about 15 min) before opening the door of the chamber.
After feeding and cleaning, we closed the door and then
slowly decreased the air pressure in the chamber until
the pressure was stabilized at 0.6 ATA (also about
15 min). Three days later, the minipigs received the same
surgery as the PI group described above, and were kept
in the hypobaric chamber with 0.6 ATA after ICH. Dur-
ing the entire experiment, an investigator was present to
observe the animals in the chamber.
Hyperbaric oxygen therapy plan
A hyperbaric pure oxygen chamber (Moon, Yantai,
China) was used. HI-HBO animals were treated once
with HBO therapy 30 min after ICH, with 2.5 ATApressure and 100 % O2, boosting pressure for 15 min,
stable pressure for one hour and reducing pressure for
15 min. Then they were sent to the hypobaric chamber
(0.6 ATA) until 24 h after ICH. The HS and HI animals
were always maintained in the hypobaric chamber for
the end time point, and the animals in the PS and PI
groups were only supplied air at normal pressure.
Multimodal monitoring
The PbtO2 probe (Lincox, Ratingen, Germany) and micro-
dialysis (MD) probe (CMA, Kista, Sweden) were inserted
and fixed firmly two hours after ICH. The positions of the
PbtO2 probe and MD probe in the perihematomal tissue
were confirmed via computed tomography, and these
probes were very close to the hematoma (Fig. 1c). The data
were collected one hour after insertion due to the unreli-
ability of readings in the initial period of time post-
insertion. Then, these parameters were continuously re-
corded from three to 12 h after ICH. Microdialysates were
perfused with a rate of 0.3 μl/min using an MD pump
(CMA, Kista, Sweden), and samples were taken every hour.
The MD vials were collected and immediately refrigerated
at −80 °C. All vials were analyzed after the experiment using
an MD automatic analyzer (CMA 600, Kista, Sweden).
Neurobehavioral evaluation
Behavior was assessed in each group 24 h after surgery
using the Purdy neurological deficit scale with moderate
modification [17]. The scale included tests of motor
Table 1 Physiological parameters in minipigs after ICH
Hours post-ICH PS (n = 6) PI (n = 10) HS (n = 6) HI (n = 10) HI-HBO (n = 10)
MAP (mmHg) 3 91.3 ± 2.5 93.8 ± 2.1 93.1 ± 2.6 94.2 ± 2.3 94.8 ± 2.2
6 91.4 ± 2.4 94.1 ± 2.0 92.2 ± 2.6 92.8 ± 2.2 94.9 ± 2.2
12 92.0 ± 2.5 93.0 ± 1.9 91.3 ± 2.4 93.7 ± 2.2 93.4 ± 2.0
Plasma glucose (mM) 3 4.45 ± 0.17 4.55 ± 0.13 4.48 ± 0.16 4.41 ± 0.12 4.49 ± 0.12
6 4.55 ± 0.17 4.48 ± 0.13 4.46 ± 0.15 4.53 ± 0.12 4.48 ± 0.12
12 4.35 ± 0.15 4.27 ± 0.12 4.36 ± 0.14 4.21 ± 0.11 4.38 ± 0.12
Core temperature (°C) 3 38.64 ± 0.06 38.73 ± 0.06 38.58 ± 0.07 38.70 ± 0.06 38.55 ± 0.08
6 38.58 ± 0.06 38.66 ± 0.06 38.53 ± 0.06 38.61 ± 0.06 38.48 ± 0.07
12 38.57 ± 0.05 38.60 ± 0.06 38.55 ± 0.06 38.53 ± 0.05 38.46 ± 0.06
pH 3 7.37 ± 0.02 7.37 ± 0.02 7.46 ± 0.03 a,b 7.47 ± 0.02 a,b 7.46 ± 0.02 a,b
6 7.38 ± 0.02 7.38 ± 0.01 7.46 ± 0.03 a,b 7.45 ± 0.02 a,b 7.48 ± 0.01 a,b
12 7.38 ± 0.02 7.39 ± 0.01 7.47 ± 0.03 a,b 7.46 ± 0.02 a,b 7.47 ± 0.02 a,b
HCO3
− (mM) 3 24.50 ± 1.31 21.82 ± 1.09 18.18 ± 0.87 a,b 18.53 ± 0.65 a,b 18.46 ± 0.66 a,b
6 24.92 ± 1.27 22.03 ± 1.19 18.46 ± 0.84 a,b 17.31 ± 0.76 a,b 18.85 ± 0.62 a,b
12 23.87 ± 1.32 22.57 ± 1.17 17.97 ± 0.91 a,b 17.73 ± 0.67 a,b 18.64 ± 0.71 a,b
SaO2 3 97.1 ± 0.5 96.4 ± 0.4 86.7 ± 0.9 a,b 86.4 ± 0.6 a,b 87.0 ± 0.7 a,b
6 97.8 ± 0.6 96.7 ± 0.5 87.3 ± 0.8 a,b 85.9 ± 0.7 a,b 86.8 ± 0.7 a,b
12 97.5 ± 0.6 97.1 ± 0.5 87.2 ± 0.8 a,b 86.5 ± 0.6 a,b 86.7 ± 0.6 a,b
PaO2 (mmHg) 3 89.7 ± 1.5 84.5 ± 1.2 67.3 ± 1.4
a,b 63.1 ± 0.9 a,b 64.3 ± 1.0 a,b
6 90.7 ± 1.8 85.6 ± 1.1 68.3 ± 1.5 a,b 63.6 ± 1.0 a,b 63.9 ± 1.0 a,b
12 88.8 ± 1.5 88.4 ± 1.2 68.8 ± 1.5 a,b 65.3 ± 1.0 a,b 66.3 ± 1.2 a,b
PaCO2 (mmHg) 3 35.1 ± 1.0 32.9 ± 0.6 25.1 ± 0.6
a,b 23.5 ± 0.5 a,b 24.8 ± 0.5 a,b
6 34.5 ± 0.9 33.8 ± 0.6 24.9 ± 0.6 a,b 24.4 ± 0.6 a,b 25.6 ± 0.6 a,b
12 33.9 ± 0.8 34.2 ± 0.7 25.4 ± 0.7 a,b 24.1 ± 0.6 a,b 25.1 ± 0.6 a,b
At each time point examined, plasma glucose, MAP and core temperature showed no significant differences between the five groups. Values of blood gas analysis
showed significant differences between the plain (low altitude) and high-altitude animals. There was no significant difference between the plain groups, and between
the high-altitude groups. HI: high altitude blood infusion group, HI-HBO: high-altitude blood infusion plus HBO therapy group, HS: high altitude sham operation group,
MAP: mean arterial blood pressure, PI: plain blood infusion group, PS: plain sham operation group
aP <0.05, compared with PS; bP <0.05, compared with PI
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to 1), circling (0 to 1) and hemianopsia (0 to 1). Neurobe-
havioral evaluation was graded on a scale of 0 to 12 (com-
pletely normal score, 0; maximal deficit score, 12). Tests
were conducted by an observer blinded to the groups.
Brain tissue water content
At 24 h after surgery, half of the animals in each group
were deeply anesthetized, and their skull was opened.
Two brain tissue samples around the hematoma of each
brain were cut and weighed. These samples were put
into an oven at 100 °C for 72 h until a constant weight
was reached. Water contents were expressed as a per-
centage of wet weight.
Nissl staining
The other half of the animals of each group were anes-
thetized, and their brains were perfused in situ with
10 % formalin. Then, the brains were soaked in 4 %paraformaldehyde solution at 4 °C for 72 h. Brain tissue
adjacent to the hematoma was cut, embedded in 30 %
paraffin and cut into 20-μm thick sections. These sec-
tions were deparaffinized with xylene and graded alco-
hol. Toluidine blue was used according to a standard
protocol. Each section was observed and photographed
under an optical microscope (Olympus, Tokyo, Japan).
Terminal deoxynucleotidyl transferase dUTP nick-end
labeling staining
The terminal deoxynucleotidyl transferase dUTP nick-
end labeling (TUNEL) assay was performed using the In
situ Cell Death Detection Kit (Roche Molecular Bio-
chemicals, Mannheim, Germany) that labels DNA strand
breaks with fluorescein isothiocyanate according to a
standard protocol. Each section was observed and
photographed under a confocal microscope (Carl Zeiss,
Oberkochen, Germany). Negative controls were obtained
by omitting the TdT enzyme. The percentage of
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TUNEL-stained nuclei divided by the total number of
4′,6-diamidino-2-phenylindole (DAPI)-stained nuclei.
Statistical analysis
All data were expressed as the means ± SEM. A model of
repeated-measures analysis of variance (ANOVA) with
post-hoc Bonferroni correction was used for analysis of
various physiological parameters. One-way ANOVA with
post-hoc Fisher’s least significant difference test was used
for neurological scores and brain edema. All analyses were
calculated using PASW software version 18 (SPSS, Chicago,
USA). Statistical significance was preset at P <0.05.
Results
Tissue oxygenation in the perihematomal tissue
All minipigs survived and were observed to the end
of the experiment. Although PbtO2 in the HS animals
was lower than in the PS animals at most of the time
points, no significant difference existed between these
two groups (P >0.05). At each time point, PbtO2 in
the PI, HI and HI-HBO animals was significantly
lower than in the PS and HS animals. Furthermore,
PbtO2 in the HI animals was significantly lower than
in the PI animals and the HI-HBO animals at each
time point (P <0.05). However, there were no signifi-
cant differences between the PI and HI-HBO animals
at any time point. PbtO2 at 11 or 12 h was signifi-
cantly higher than at three hours in the HI-HBO ani-
mals (Fig. 2a).
Cerebral metabolism in the perihematomal tissue
There was no significant difference between the PS and
HS animals in glucose, lactate, lactate/pyruvate ratio
(LPR) and glutamate (P >0.05). At each time point, glu-
cose in the PI, HI and HI-HBO animals was significantly
lower than in the PS and HS animals (P <0.05). Al-
though glucose in the HI animals was lower than in the
PI and HI-HBO animals at most of the time points, no
significant difference was observed among the three
groups (Fig. 2b). Lactate was significantly higher at five or
six hours than at 12 h in the HI animals, and it was signifi-
cantly higher at six hours than at 11 or 12 h in the HI-
HBO animals. At each time point, lactate in the PI, HI
and HI-HBO animals was significantly higher than in the
PS and HS animals (P <0.05). Although lactate in the HI
animals was higher than in the PI and HI-HBO animals at
most of the time points, there was no significant differ-
ence among the three groups (Fig. 2c). It was significantly
higher at six hours than at 12 h in the HI and HI-HBO an-
imals about LPR. At each time point, LPR in the PI, HI
and HI-HBO animals was significantly higher than in the
PS and HS animals (P <0.05). Furthermore, LPR in the HI
animals was significantly higher than in the PI and HI-HBO animals (P <0.05). However, there was no significant
difference between the PI and HI-HBO animals (Fig. 2d).
Glutamate was significantly higher at four hours than at
12 h in the HI and HI-HBO animals. It was also signifi-
cantly higher in the PI, HI and HI-HBO animals than in
the PS and HS animals (P <0.05). Furthermore, it was sig-
nificantly higher in the HI animals than in the PI and HI-
HBO animals at each time point (P <0.05). No significant
difference existed in the PI and HI-HBO animals (Fig. 2e).
Neurological deficits and brain edema
There was no significant difference between the PS and
HS animals in neurological scores or brain water con-
tent. High-altitude ICH showed more serious impair-
ments in neurological functioning than low-altitude ICH
(P <0.05). Further, there was significant improvement in
neurological deficits after HBO treatment at 24 h post-
injury (Fig. 3a). High-altitude ICH also showed higher
brain water content than low-altitude ICH (P <0.05).
After HBO treatment, brain water content was signifi-
cantly decreased 24 h after ICH (Fig. 3b).
DNA damage and neuronal damage in perihematomal
tissue
At 24 h post-ICH, coronal brain slices showed oval-
shaped hematomas at the right basal ganglia (Fig. 4a). PS
and HS animals showed lots of stained neurons with
normal structure in Nissl staining. A decrease in the
number of stained cells, as well as unclear or damaged
structure in most of the neurons around the hematoma,
were shown in PI animals. Furthermore, the decrease in
the number of stained cells and structural damage of the
neurons was more severe in the HI animals when com-
pared with the PI animals. However, the neuronal dam-
age in the HI-HBO group was less than that in the
HI group (Fig. 4b). In addition, similar results for DNA
damage were found with TUNEL staining. TUNEL-
positive cells were evident in the perihematomal tissue
at 24 h post-ICH. The number of TUNEL-positive cells
around the hematoma increased dramatically in the HI
group compared with the PI group (P <0.05). Signifi-
cantly fewer TUNEL-positive cells were found in the HI-
HBO group (Fig. 4c).
Discussion
High-altitude ICH has been a somewhat obscure clinical
problem to date, and there is a severe lack of experimen-
tal animal research into high-altitude ICH. In this animal
study, high-altitude ICH animals manifested lower
PbtO2, higher levels of LPR and glutamate, and more se-
vere brain lesion and neurological outcomes than low-
altitude ICH. HBO treatment (2.5 ATA for 60 min)
30 min after high-altitude ICH improved cerebral physi-
ology, pathological damage and neurological deficit. One
Fig. 3 Changes in neurological functioning and brain edema 24 h after ICH. a High-altitude ICH showed more serious neurological function
impairments than low-altitude ICH. However, there was no significant difference between HI and HI-HBO animals. b High-altitude ICH also
showed more serious brain edema than low-altitude ICH. Moreover, brain water content in HI-HBO animals significantly decreased. *P <0.05
Fig. 2 Changes in cerebral oxygenation and metabolism from three to 12 h post-ICH. a At each time point, PbtO2 in HI animals was significantly
lower than in PI animals, and it was significantly elevated in HI-HBO animals. b Although the level of glucose in HI animals was lower than in the
PI or HI-HBO animals at most of the time points, there was no significant difference between the three groups. c Likewise, lactate in HI animals
was higher than in the PI or HI-HBO animals at all time points, but no significant difference existed between them. d LPR in HI animals was significantly
higher than in the PI and HI-HBO animals at each time point. e Likewise, glutamate in HI animals was significantly higher than in the PI and HI-HBO
animals at each time point. #P <0.05, compared with PI; *P <0.05, compared with HI-HBO
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Fig. 4 Nissl and TUNEL staining of the perihematomal tissue 24 h after ICH. a Coronal brain slice shows oval-shaped hematomas at the right basal
ganglia. b Nissl staining showing a decrease in the number of stained cells and more severe structural damage of the neurons around the hematoma in
HI animals. However, the neuronal damage in HI-HBO animals was reduced. Right arrow indicates normal neuron, up arrow indicates damaged neuron
in the photos. c Quantification analysis indicating TUNEL-positive cells increased in HI animals and decreased in HI-HBO animals. The percentage of
TUNEL-positive cells was expressed as the number of TUNEL-stained nuclei divided by the total number of DAPI-stained nuclei. *P <0.05. Bar = 100 μm
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treatment attenuates brain injury is the modulation of
cerebral oxygenation and metabolism during experimen-
tal high-altitude ICH.
PbtO2, the partial pressure of oxygen in the extracellu-
lar fluid of the brain tissue, reflects the availability of
oxygen for oxidative energy production. Although PbtO2
does not directly assess cerebral blood flow, it is a com-
plex and dynamic parameter representing the interaction
between the delivery and demand of brain oxygen, as
well as oxygen diffusion gradients [11]. PbtO2 monitor-
ing can be used to identify cerebral perfusion pressure
targets for optimal brain tissue oxygenation, and low
perihematomal PbtO2 correlates with poorer outcomes
after ICH [10]. In this study, high-altitude ICH showed
lower PbtO2 than low-altitude ICH in the acute stage, and
no significant difference in MAP existed between these
groups. In addition to MAP, changes in arterial oxygen-
ation can influence PbtO2 following ICH [18]. Therefore,
the low PaO2 in response to hypobaric hypoxia may be an
important cause of the worse cerebral oxygenation post-
ICH. The observation that lower PbtO2 occurred in ani-
mals exposed to hypobaric hypoxia rather than normoxia
after head trauma was consistent with our findings [19].
Despite some indicators of hypoperfusion, true ische-
mia in the perihematomal region was difficult to prove
because of disproportionate reductions in the cerebral
metabolic rate for oxygen and preserved oxygenextraction fractions in the perihematomal tissue [20]. A
switch of concept from ischemic to metabolic penumbra
was suggested recently. The transient focal increases in
glucose metabolism have been interpreted as signs of
ongoing neuronal injury in the metabolic penumbral tis-
sue [21]. One or more non-ischemic mechanisms may
contribute to this change in energy metabolism, includ-
ing neuroinflammation, cytotoxicity or seizure activity.
The interstitial glucose concentration is attributed to the
balance between delivery from the blood capillaries and
the cellular uptake. A low level of glucose was associated
with worse outcome after brain injury [10]. In this study,
a decrease in interstitial glucose concentration in the
early phase, which was interpreted as an increase in glu-
cose consumption, was observed after ICH. However,
hypobaric hypoxia did not result in markedly lower glu-
cose than normoxia post-ICH. One reason may be that
hypoxia induces an increase in cerebral glucose concen-
trations in response to increased glucose transporters
in brain microvessels and blood-to-brain glucose influx
[22]. Another may be regional-specific changes in the
cerebral glucose metabolism exposed to hypobaric hyp-
oxia [23, 24]. Additionally, the cerebral glucose con-
sumption may reach maximal capacity, so the glucose
level is maintained at its lowest level possible. Serum
glucose levels can affect cerebral glucose metabolism,
so systemic glucose variability may be associated with
poor outcome in critically ill patients [25]. However,
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was low in this study due to the similar levels of serum
glucose in each group.
In addition to reduced extracellular glucose, elevated
lactate is also observed in some brain injury studies [26].
Additionally, lactate accumulations or pyruvate de-
creases in the extracellular space lead to an increase in
LPR, which reflects the oxidative metabolism within the
cytoplasm. In this study, cerebral lactate and LPR in-
creased and were sustained until the end time point.
Furthermore, patients after surgical evacuation of a
hematoma with a poor outcome had significantly higher
lactate and LPR than patients with a good outcome [27].
Although cerebral lactate may increase at high altitude
[28, 29], lactate did not dramatically elevate after ICH at
high altitude compared to low altitude in our study. We
speculate that lactate may be used as an alternate energy
source for neurons, potentially via shuttling of glycolyti-
cally derived carbons from astrocytes, especially in hyp-
oxia [30]. Another ICH study reported that LPR and
intracranial pressure decreased after mannitol adminis-
tration despite a lack of increase in MD glucose, pyru-
vate and PbtO2 [31]. Recently, LPR has been interpreted
as energy metabolic distress in the absence of ischemia,
which possibly results from mitochondrial dysfunction,
seizures or reduced substrate availability. In the present
study, larger increases in LPR induced by hypobaric hyp-
oxia indicate worse energy metabolism dysfunction at
high altitude than at low altitude in the early stages
post-ICH. Increased LPR in the bronchoalveolar fluid
was also observed in high-altitude lung injury [32].
Elevated glutamate levels in the perihematomal region
after ICH have been demonstrated in some low-altitude
studies [33], and our data of glutamate are consistent
with this finding. Glutamate activation of NMDA or
AMPA receptors can result in increased glucose metab-
olism in perihematomal tissue after ICH [34]. Further-
more, our results suggest a higher accumulation of
glutamate around the hematoma soon after high-altitude
ICH. The expression change in glutamate receptors,
such as NR1 and GluR2, mediates glutamate excitotoxi-
city in chronic hypobaric hypoxia [35]. These observa-
tions of multi-parameters show the complex features
of brain metabolism as a function of substrate delivery,
transport and consumption in the variable demand of
the injured brain, especially at high altitude. Any inter-
pretation of one single factor is limited by virtue of its
intricate nature. Thus, more severe brain oxygenation
reduction, energy metabolism dysfunction and glutamate
accumulation occur jointly in the early stages of high-
altitude ICH characterized by hypobaric hypoxia. Direct
or indirect actions of cerebral oxygenation and energy
metabolism distress, as well as glutamate excitotoxicity,
synergistically elicit the death and degeneration of neuralcells, which aggravates brain edema and cerebral damage
after high-altitude ICH.
HBO has been widely used as the primary therapy in
patients with decompression sickness, carbon monoxide
poisoning and arterial gas embolism. Plenty of studies
suggest that HBO treatment is effective in brain injury
at low altitude. Early HBO therapy mitigates blood–
brain barrier disruption and suppresses the progression
of brain edema post-ICH by preventing occludin degrad-
ation and matrix metalloproteinase-9 activation in the
perihematomal tissue [36]. In a murine ischemic stroke
study, altered striatal energy metabolites and glutamate
can be regulated by HBO, which might contribute to the
neuroprotection of HBO therapy [37]. Additionally, nor-
mobaric hyperoxia also increases brain tissue oximetry,
with a variable effect on lactate and LPR in severe trau-
matic brain injury patients [38]. Another study reported
that HBO improved PbtO2 and metabolic distress, and
had a more robust post-treatment effect than normoba-
ric hyperoxia on oxidative cerebral metabolism, related
to its ability to produce a PbtO2 of 200 mmHg or higher
[13]. After early HBO treatment, an increase in PbtO2
may improve cerebral metabolism, cerebrovascular auto-
regulation, cerebral blood flow, neuroinflammation and
brain edema. In turn, improvements in these can raise
cerebral oxygenation. In this study, early HBO therapy
also markedly elevated PbtO2 for 12 h in hypobaric
hypoxia. A study about high-altitude brain injury also
reported that HBO treatment can increase PbtO2 and
regional cerebral blood flow 24 h after brain injury and
benefit recovery [19]. HBO treatment following high-
altitude ICH alleviated secondary brain injury and
neurological deficits, which was attributed to amelio-
rated brain tissue oxygenation, energy metabolism
dysfunction and glutamate excitotoxicity. HBO therapy
has also been applied in many other diseases at high alti-
tude. One hour of treatment in a portable hyperbaric
chamber leads to a short-term improvement in symp-
toms of acute mountain sickness [39]. Improvements in
the focal oxygen supply by HBO ameliorated calcific
uremic arteriolopathy in high-altitude areas [40]. Add-
itionally, high-altitude pulmonary edema and lung injury
can be reduced by an induction of heat-shock protein 70
in the lung in response to HBO preconditioning [41].
There are some limitations to this study. First, main-
tenance in a hypobaric chamber for three days may be
too short to totally emulate the long duration of ICH
formation at high altitude. However, it must be noted
that the current study was intended to be a hypothesis-
generating pilot study. The absence of intracranial pres-
sure and cerebral perfusion pressure monitoring is an-
other limitation. Additionally, because our autologous
blood injection model does not mimic small vessel
rupture in ICH, microvascular breakdown effects are
Zhu et al. Critical Care  (2015) 19:255 Page 9 of 10difficult to assess. Furthermore, the size of the sample is
small and a larger number is needed for further
investigation.
Conclusions
Our findings indicate more serious disturbance of tissue
oxygenation and cerebral metabolism, as well as worse
brain pathology and neurological outcomes, in high-
altitude ICH in comparison to low-altitude ICH in the
acute stages in our porcine model. Early HBO treatment
reduced brain edema and tissue damage via amelioration
of cerebral oxygenation and metabolism, and this may
be an important mechanism whereby HBO attenuates
secondary brain injury following high-altitude ICH. All
the data support modulation of tissue oxygenation and
cerebral metabolism in perihematomal tissue as a poten-
tial therapeutic target, and suggest that early HBO treat-
ment may be beneficial for ICH at high altitude.
Key messages
 High-altitude ICH shows more serious disturbance
of tissue oxygenation and cerebral metabolism in
comparison to low-altitude ICH in the acute stages.
 Early HBO treatment reduced acute brain injury
through a mechanism involving the amelioration of
the derangement of cerebral oxygenation and
metabolism following high-altitude ICH.
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